(S)-N-(2-Amino-1-(4-(2-hydroxyethyl)thiazol-2-yl)ethyl)-5-(2-fluoro-4-(trifluoromethyl)phenyl)-1H-pyrrole-2-carboxamide

ID: ALA5278363

Chembl Id: CHEMBL5278363

Max Phase: Preclinical

Molecular Formula: C19H18F4N4O2S

Molecular Weight: 442.44

Associated Items:

Names and Identifiers

Canonical SMILES:  NC[C@H](NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2F)[nH]1)c1nc(CCO)cs1

Standard InChI:  InChI=1S/C19H18F4N4O2S/c20-13-7-10(19(21,22)23)1-2-12(13)14-3-4-15(26-14)17(29)27-16(8-24)18-25-11(5-6-28)9-30-18/h1-4,7,9,16,26,28H,5-6,8,24H2,(H,27,29)/t16-/m0/s1

Standard InChI Key:  BNLIEBFODQIJGR-INIZCTEOSA-N

Alternative Forms

  1. Parent:

    ALA5278363

    ---

Associated Targets(Human)

TZM (838 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
env Envelope glycoprotein gp160 (755 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 442.44Molecular Weight (Monoisotopic): 442.1087AlogP: 3.26#Rotatable Bonds: 7
Polar Surface Area: 104.03Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 13.85CX Basic pKa: 8.37CX LogP: 2.06CX LogD: 1.05
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.42Np Likeness Score: -1.21

References

1. Curreli F, Ahmed S, Benedict Victor SM, Iusupov IR, Spiridonov EA, Belov DS, Altieri A, Kurkin AV, Debnath AK..  (2021)  Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitors.,  32  [PMID:33461144] [10.1016/j.bmc.2021.116000]

Source